Skip to content
DeeptechNavigator

Patent intelligence · Companies

Company patent strength

Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.

Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.

Why this page exists — and how to read it

Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.

Investors
High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
Founders & operators
These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
Corporate & R&D
Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.

💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.

Domestic (India)Foreign applicants
Portfolio sizeGrant rateLapsed

3,207 foreign filers with 5+ patents · page 62

#FilerPatentsGrantedLapsedPendingActive
3051REVVITY HEALTH SCIENCES500%052024–2026
3052RHYTHM PHARMACEUTICALS500%052022–2025
3053RICH PRODUCTS500%052022–2025
3054ROCKY RESEARCH5120%312022–2023
3055ROHDE SCHWARZ KG500%052023–2023
3056RSTED WIND POWER A S500%142022–2023
3057RUBICON RESEARCH PTY5360%022022–2024
3058RYNAN TECHNOLOGIES500%142022–2026
3059SAFEGRID500%052024–2025
3060SAFRAN ELECTRONICS DEFENSE5240%032019–2024
3061SAFRAN LANDING SYSTEMS500%052024–2026
3062SAINT GOBAIN PAM CANALISATION5120%042022–2025
3063SAKATA INX500%142022–2025
3064SAKO500%052022–2022
3065SALTS HEALTHCARE5120%222021–2023
3066SALVAGNINI ITALIA5120%132022–2025
3067SAPREME TECHNOLOGIES500%412022–2023
3068SARAS 3D500%052024–2026
3069SARTORIUS STEDIM NORTH AMERICA500%052022–2025
3070SASOL CHEMICALS5240%032021–2023
3071SAWAI PHARMACEUTICAL500%052024–2025
3072SCHLEUNIGER500%232023–2026
3073SCHNEEBERGER HOLDING500%052023–2025
3074SCHR DINGER500%052022–2025
3075SEAKEEPER500%052024–2025
3076SECARNA PHARMACEUTICALS KG500%142022–2025
3077SEKISUI TECHNO MOLDING5120%042021–2025
3078SENNICS500%052022–2025
3079SENS AI5120%042022–2024
3080SENSE BIODETECTION500%412022–2023
3081SETOLAS HOLDINGS500%052023–2025
3082SEURAT TECHNOLOGIES500%052023–2023
3083SHANDONG WEIFANG RAINBOW CHEMICAL500%052023–2025
3084SHANGHAI FUDAN ZHANGJIANG BIO PHARMACEUTICAL5120%042022–2024
3085SHANGHAI HIGHLY ELECTRICAL APPLIANCES500%052025–2026
3086SHANGHAI JEMINCARE PHARMACEUTICALS5240%032022–2023
3087SHAPERON5120%042023–2024
3088SHENZHEN HUACHENGDA PRECISION INDUSTRY5480%012022–2023
3089SHENZHEN INCRECARE BIOTECH5120%042022–2025
3090SHENZHEN JISU TECHNOLOGY500%052024–2025
3091SHENZHEN LIFETECH RESPIRATION SCIENTIFIC500%142023–2024
3092SICHUAN HUIYU PHARMACEUTICAL500%142024–2026
3093SIEMENS HEALTHCARE5120%042023–2023
3094SIEMENS MOBILITY AUSTRIA5240%032022–2026
3095SIFI5120%042022–2023
3096SIG TECHNOLOGY500%052022–2022
3097SILENTIUM500%052023–2025
3098SILVERWELL TECHNOLOGY500%052025–2026
3099SIMPLIFYBER500%052025–2025
3100SINGAPORE HEALTH SERVICES500%142022–2025
← PreviousNext →

Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →

Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →